OncoLink Cancer Treatment and Resources

Interferon Treatment for Melanoma

Last Modified: March 12, 2006

Question

Dear OncoLink "Ask The Experts,"

I have had a block dissection of the lymph nodes, and the sentinel node was found to contain melanoma cells. I am shortly going on a treatment course of interferon. Is there anything else I can do to improve my chances of survival? What do the statistics predict as my chances of survival? Your advice in this regard would be greatly appreciated.

Answer

Suzanne M. McGettigan, MSN, CRNP, AOCN, Board Certified Adult Nurse Practitioner and a Certified Oncology Advanced Practice Nurse, responds:

Interferon is the only FDA-approved treatment for Stage III melanoma. High-dose interferon is given intravenously, five days a week for a month, and then subcutaneously (or into fatty tissue) for the remaining 11 months. Interferon treatment is surrounded by much controversy. This treatment has been associated with an improvement in disease-free survival, but not overall survival (Hurley & Chapman, 2005; Kirkwood et al., 2000; Kirkwood, et al., 1996). This implies that there is a slightly longer time to the development of a recurrence, but no time difference in overall survival when comparing interferon to observation alone. Additionally, interferon is associated with significant toxicities. Patients undergoing high-dose interferon experience depression, fatigue, generalized malaise, flu-like symptoms, abnormal liver function tests, weight loss, and an inability to carry out activities of daily living. For these reasons, some stage III patients choose to not have therapy.

There is no evidence that a special diet can prevent recurrence of the first melanoma or occurrence of a second melanoma in another location. A generally healthy lifestyle is always a good step towards overall health and well-being. This would include sun-avoidance behaviors, regular exercise, and a healthy diet.

OncoLink I wish u knew...

Common misconceptions and myths about pain medication and pain control. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy

Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews


Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement

OncoLink Cancer Resources RSS What's New RSS